Nahed Ismail, M.D., M.Sc., Ph.D., SM(ASCP), D(ABMM)
Associate Professor
Pathology
West Basic Sciences Center, Room 4142

Phone: (615) 327-6364

nismail@mmc.edu

 
 
Dr. Ismail's Publications
 
Professional Education
Dates Attended
Institution Name
City, State Degree/Area of Study
2000-2002
University of Texas Medical Branch
Galveston, Texas
Clinical Microbiology Fellow
1996-2000
University of Saskatchewan
Saskatchewan, Canada
Ph.D.
1993-1995
University of Toronto
Ontario, Canada
M.Sc.
1982-1988
Tanta University
Tanta, Egypt
M.D.

 

Research Interests / Specialty

NIH/NCRR 1KL 2RR 024977 Gordon B (PI) 09/01/2008 - 08/31/2012
Role: Director of Oral Pathogen Core Vanderbilt Institute for Clinical and Translational Research

NIH/NCRR 5g12RR003032 James g. Townsel (PI) 08/1/08-7/30/2010
Role: RCMI investigator, Meharry Medical College

NIH/NIAID (RO1 AI 21242) Walker DH (PI) Ismail N. (Subcontract) 07/01/09-06/30/14
Spotted Fever Rickettsial Antigens
Long-term goal: elucidation of the mechanisms of protective immunity against spotted fever group rickettsiae.

Publications/Scholarly Activities
  • Jere W. McBride, Juan Olano, Nahed Ismail. Molecular diagnosis of Ehrlichia infection.Taylor & Francis Group (CRC Press), Molecular Detection of Human Bacterial Pathogens, Dongyou Liu, 2009.
  • Nahed Ismail, Karen C. Bloch, Jere W. McBride. Human Ehrlichiosis and Anaplasmosis. The Clinics in Laboratory Medicine, Atlas of Emerging Infectious Diseases, editors; William Pasculle and James Snyder. Elsevier, 2009.
  • Thirumalapura NR, Emily Crossley, David H. Walker and Nahed Ismail. Persistent infection contributes to heterologous protection against fatal ehrlichiosis, the J. of Immunology, Favorable review, revised 2009.
  • Fang Rong, Nahed Ismail, David. H. Walker. CD4+CD25+ Foxp3-CTLA-4+ T regulatory cells are the major source of IFN and IL-10 in acute fatal rickettsial infection. Infection and Immunity, 2009. PMID: 19564386
  • Duane Hamilton, Nahed Ismail, David Kroeger, Christopher Rudulier, Peter Bretscher. Macroimmunology and immunotherapy of cancer. Immunotherapy, 31:296-303, 2009.

 

 

 

 

 

© 2009 Meharry Medical College
1005 Dr. D.B. Todd Jr., Blvd.
Nashville, TN, 37208
(615) 327-6111

Last Updated: April 25, 2011